HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistent jaundice in an infant with homozygous beta thalassemia due to co-inherited Crigler-Najjar syndrome.

Abstract
Clinically apparent jaundice is unusual in patients with beta-thalassemia major. Co-inheritance of Gilbert syndrome has been reported to cause hyperbilirubinemia in these subjects. Crigler-Najjar syndrome is another rare disorder of bilirubin metabolism caused by mutation in the gene coding the enzyme UGT1A1. We report a patient of beta-thalassemia major who presented with persistent jaundice due to co-inherited Crigler-Najjar syndrome type 2 secondary to a novel mutation in UGT1A1 gene [homozygous base substitution at position 362 (GGT>AGT) in exon 3].
AuthorsVarun Aggarwal, Anju Seth, Sunita Sharma, Satinder Aneja, Pietro Sammarco, Carmelo Fabiano
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 54 Issue 4 Pg. 627-8 (Apr 2010) ISSN: 1545-5017 [Electronic] United States
PMID19953640 (Publication Type: Case Reports, Journal Article)
Chemical References
  • GABA Modulators
  • UGT1A1 enzyme
  • Glucuronosyltransferase
  • Phenobarbital
Topics
  • Crigler-Najjar Syndrome (complications, genetics, therapy)
  • Erythrocyte Transfusion
  • Fatal Outcome
  • GABA Modulators (therapeutic use)
  • Glucuronosyltransferase (genetics)
  • Humans
  • Infant
  • Jaundice (genetics)
  • Male
  • Mutation
  • Phenobarbital (therapeutic use)
  • beta-Thalassemia (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: